Frederiksberg, Denmark

Jens Peter Norgaard

This inventor holds 4 USPTO granted patents and 2 published patent applications. Top assignee: Ferring B.v.. Active years: 2018-2024.

USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 2.2

ph-index = 3

Forward Citations = 12(Granted Patents)


Company Filing History:


Years Active: 2018-2024

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Jens Peter Norgaard

Introduction

Jens Peter Norgaard is a notable inventor based in Frederiksberg, Denmark. He has made significant contributions to the field of medicine, particularly in the development of methods to improve patient care. With a total of 4 patents to his name, Norgaard's work has had a meaningful impact on healthcare practices.

Latest Patents

Among his latest patents, Norgaard has developed methods comprising desmopressin. The present disclosure is directed to reducing nocturnal voids by administering a dose of desmopressin over a minimum treatment period compared to before administration. This innovation aims to maintain or improve the reduction of nocturnal voids over the minimum treatment period, showcasing his commitment to enhancing patient outcomes.

Career Highlights

Norgaard is currently associated with Ferring B.V., a company known for its focus on innovative pharmaceuticals. His work at Ferring B.V. allows him to collaborate with other experts in the field and contribute to groundbreaking research and development.

Collaborations

Some of his notable coworkers include Bjarke Mirner Klein and Bjarke Mimer Klein. Their collaboration has likely fostered an environment of innovation and creativity, further enhancing the quality of their work.

Conclusion

Jens Peter Norgaard's contributions to the field of medicine through his patents and collaborations highlight his dedication to improving healthcare. His innovative methods continue to pave the way for advancements in patient care.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…